01 1SM Biomed SDN.BHD.
01 1Hiple Co., Ltd.
01 1Erythromycin
01 1Malaysia
Registrant Name : Hiple Co., Ltd.
Registration Date : 2015-11-17
Registration Number : 20120601-107-F-64-02(1)
Manufacturer Name : SM Biomed SDN.BHD.
Manufacturer Address : Lot 90, Sungai Petani Industrial Estate, 08000 Sungai Petani, Kedah, Malaysia (Erythr...
84
PharmaCompass offers a list of Erythromycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Erythromycin manufacturer or Erythromycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Erythromycin manufacturer or Erythromycin supplier.
A Pantomicina manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pantomicina, including repackagers and relabelers. The FDA regulates Pantomicina manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pantomicina API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pantomicina manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Pantomicina supplier is an individual or a company that provides Pantomicina active pharmaceutical ingredient (API) or Pantomicina finished formulations upon request. The Pantomicina suppliers may include Pantomicina API manufacturers, exporters, distributors and traders.
click here to find a list of Pantomicina suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pantomicina Drug Master File in Korea (Pantomicina KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pantomicina. The MFDS reviews the Pantomicina KDMF as part of the drug registration process and uses the information provided in the Pantomicina KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pantomicina KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pantomicina API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pantomicina suppliers with KDMF on PharmaCompass.
